Literature DB >> 4398190

Daunorubicin metabolism by rat tissue preparations.

N R Bachur, M Gee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4398190

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Uptake and metabolism of daunorubicin by human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

2.  Plasma kinetics of aclacinomycin A and its major metabolites in man.

Authors:  M J Egorin; D Van Echo; B M Fox; M Whitacre; N R Bachur
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus.

Authors:  M Blumauerová; E Královcová; J Matĕjů; J Jizba; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

4.  Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.

Authors:  B J Cusack; S P Young; J Driskell; R D Olson
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.

Authors:  D L de Valeriola; D D Ross; A Forrest; D P Cuddy; M J Egorin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Daunorubicin metabolism: estimation of daunorubicin reductase.

Authors:  N R Bachur; D H Huffman
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

7.  Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin.

Authors:  Zhiyuan Xu; Ronghua Ni; Yun Chen
Journal:  Int J Nanomedicine       Date:  2019-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.